Coronary, Peripheral, and Structural Interventions

The Coronary, Peripheral, and Structural Interventions Learning Pathway at ACC.26 will spotlight the latest advances in interventional cardiology, from managing cardiogenic shock to navigating the evolving landscape of transcatheter tricuspid valve therapies. Expert faculty from around the globe will address pressing challenges, emerging technologies and practice-changing debates shaping the field today.

This year's program dives into innovations in technology and therapy, from drug-coated balloons and radiation protection to building effective renal denervation programs. Attendees will explore complex case management and high-risk interventions, including strategies for treating peripheral vascular disease and updated guidance for acute coronary syndromes. Finally, sessions on structural heart controversies will tackle the ongoing debates in TAVR and tricuspid valve therapies, providing the latest insights on treatment selection, imaging and device interaction.

Sessions You Don't Want to Miss:

• Top Interventional Trials of 2025: The Gloves Are Off! (Session 247)
• Updates in ACS Guidelines: Remaining Controversies (Session 235)
• No Metal, No Problem: Expanding Roles For Drug-Coated Balloons (Session 320)
• Renal Denervation: A Game Changer in Hypertension Therapy (Session 353)
• The Third Rail: Dilemmas in Transcatheter Tricuspid Valve Therapy (Session 362)
• Cardiogenic Shock in 2026: What Next After DanGer Shock? (Session 265)
• TAVR Politics: The 2026 Debates (Session 295)

Join us for cutting-edge insights, practical tools, and lively discussions to advance your interventional practice.